Passive immunotherapy of cancer in animals and man.
D000818:Animals; D000906:Antibodies; D000910:Antibodies, Heterophile; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001667:Binding, Competitive; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D066298:In Vitro Techniques; D007518:Isoantibodies; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D012313:RNA / Q000276:immunology; D013347:Subcellular Fractions / Q000276:immunology; D014165:Transfer Factor / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000906:Antibodies; D000910:Antibodies, Heterophile; D000970:Antineoplastic Agents; D007518:Isoantibodies; D014165:Transfer Factor; D012313:RNA